InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

CPV Insider Trading

Insider Ownership Percentage: 35.00%
Insider Buying (Last 12 Months): A$79,124.60
Insider Selling (Last 12 Months): A$0.00

ClearVue Technologies Insider Trading History Chart

This chart shows the insider buying and selling history at ClearVue Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ClearVue Technologies Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 06/11/2021 12:08 PM ET

This chart shows the closing price history over time for CPV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

ClearVue Technologies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/26/2024Jamie LyfordInsiderIssued20,000A$0.50A$10,000.00
8/11/2023Gerd HoenickeInsiderBuy236,900A$0.33A$79,124.60
6/10/2021Victor RosenbergInsiderBuy3,146,506A$0.25A$786,626.50
See Full Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for ClearVue Technologies (ASX:CPV)

0.09% of ClearVue Technologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

ClearVue Technologies logo
ClearVue Technologies Limited, together with its subsidiaries, provides building-integrated photovoltaic solutions in Australia. It offers CLEARVUEPV, a solar window; SMARTVUEPV, a self-powered smart autonomous window; and ARTPV, an imaged solar window. The company was formerly known as Tropiglas Technologies Limited. ClearVue Technologies Limited was incorporated in 1995 and is headquartered in West Perth, Australia.
Read More on ClearVue Technologies

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.55

Who are the company insiders with the largest holdings of ClearVue Technologies?

ClearVue Technologies' top insider shareholders include:
  1. Gerd Hoenicke (Insider)
  2. Jamie Lyford (Insider)
Learn More about top insider investors at ClearVue Technologies.
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...